1. Biotechnology foundations and innovations
From the chemistry of biological building blocks to AI-driven analysis of disease, take a deep dive into the disciplines shaping the future of biotechnology!
- Artificial intelligence and big data
- Chemical and biochemical engineering
- Chemistry and biochemistry
- Bioinformatics
- Cell biology
- DNA technologies
- Genetics
- Metabolic engineering
- Microbiology
- Nanobiotechnology
- Protein technologies
- Synthetic biology
Track chair
Greg Stephanopoulos
Willard Henry Dow Professor in Chemical Engineering
Massachusetts Institute of Technology
Greg Stephanopoulos biography
Dr. Greg Stephanopoulos is presently the W.H. Dow Professor of Chemical Engineering and Biotechnology at MIT, and Instructor of Bioengineering at Harvard Medical School (1997-). He received his Bachelor of Science from the National Technical University of Athens, his Masters of Science from the University of Florida, and his PhD from the University of Minnesota, all in chemical engineering. He taught at Caltech between 1978-85, after which he was appointed Professor of chemical engineering at MIT.
His current research focuses on metabolic engineering, the engineering of microbes for the production of fuels and chemicals. He is a co-author of the first textbook on metabolic engineering, and currently directs a research group of approximately 25 researchers in this field. He has co-authored or –edited 5 books, more than 425 papers and 50 patents and mentored more than 150 graduate and post-doctoral students. He is the editor-in-chief of Metabolic Engineering and Current Opinion in Biotechnology and serves on the editorial boards of 10 scientific journals and the advisory boards of five chemical engineering departments.
For his research and educational contributions, Dr. Stephanopoulos has received more than 20 major awards including the Eni Prize for Renewable and non-Conventional Energy. He is a member of the National Academy of Engineering and Academy of Athens and currently serves as President of the American Institute of Chemical Engineers.
Keynote speakers
Bugs as drugs: microbial ecosystem therapeutics to treat gut dysbiosis
Emma Allen-Vercoe
Professor of Molecular and Cellular Biology, University of Guelph
Co-founder, NuBiyota
Guelph, Canada
Body on a chip systems to improve drug development
Michael L. Shuler
Samuel B. Eckert Professor of Engineering
Cornell University
Ithaca, USA
CRISPR-Cas systems : from humble beginnings to today’s headlines
Sylvain Moineau
Canada Research Chair in Bacteriophages
Université Laval Québec, Canada
Invited speakers
Methods for real-time monitoring of pathogens
Abdoulaye Baniré Diallo
Professor & Director, Bioinformatics Lab
Université du Québec à Montréal
Montréal, Canada
Improving land restoration of sites impacted by natural resources exploitation through the study of soil and tree root-associated microbiomes
Armand Séguin
Research Scientist, Forest Genomics
Laurentian Forestry Centre
Québec, Canada
Digital biomanufacturing will enable advanced theranostics
Bill Whitford
Strategic Solutions Leader
GE Healthcare
Logan, USA
Targeting tumors with bispecific antibodies and drug conjugates
John Babcook
Senior Vice-President, Discovery and Research
Zymeworks
Vancouver, Canada
Systematic processing of microbiome genomics sequencing data
Julien Tremblay
Associate Research Officer, Bioinformatics
Energy, Mining and Environment
National Research Council Canada
Montréal, Canada
Real-time phase contrast X-ray imaging using a lab source for biotechnology applications
Dr. Karim Karim
Professor, Electrical and Computer Engineering
Waterloo Institute for Nanotechnology, University of Waterloo
Waterloo, Canada
Development of next-generation probiotics: bugs to tackle metabolic syndrome
Mathieu Millette
Scientific Director, Preclinical Research Division
Bio-K+ International Inc.
Montreal, Canada
The future of drug development depends on more efficient in vitro models of human diseases
Margaret Magdesian
Founder and CEO
ANANDA Devices
Montreal, Canada
Gold nanoparticles: from protein recognition to protein mimicry
Paolo Scrimin
Professor, Department of Chemical Sciences
Università di Padova
Padua, Italy
Sequence-based interrogation of microbiomes
Susannah Green Tringe
Deputy Director, User Programs
Microbial Systems Group Lead
DOE Joint Genome Institute
Walnut Creek, USA
The impact of antibiotics and probiotics on the microbiome, resistome, and associated diarrhea
Thomas A. Tompkins
Research Director
Lallemand Health Solutions
Montréal, Canada
Application of Microbiome Analysis to Controlled Environment Agriculture
Trevor C. Charles
Professor, Department of Biology
Director, Waterloo Centre for Microbial Research
University of Waterloo
Waterloo, Canada
- Date modified: